A detailed history of Ewa, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ewa, LLC holds 1,692 shares of NVO stock, worth $201,466. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,692
Previous 1,716 1.4%
Holding current value
$201,466
Previous $220 Million 2.38%
% of portfolio
0.09%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$122.71 - $146.91 $2,945 - $3,525
-24 Reduced 1.4%
1,692 $226 Million
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $75,765 - $100,852
-742 Reduced 30.19%
1,716 $220 Million
Q4 2023

Feb 05, 2024

BUY
$87.78 - $105.45 $526 - $632
6 Added 0.24%
2,458 $279 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $222,984 - $489,272
2,452 New
2,452 $247 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $158,278 - $190,331
1,196 New
1,196 $205 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ewa, LLC Portfolio

Follow Ewa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.